Medivis, Inc. — Form D
Medivis, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-06. The offering totals $25.0M, of which $22.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-09-06
- Form: D
- Accession: 0001939642-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $25.0M
- Amount sold: $22.0M
- Remaining: $3.0M
- Investors: 25
- Date of first sale: 2022-08-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-458085
Issuer
- Name: Medivis, Inc.
- CIK: 0001939642
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 174 FIFTH AVENUE, NEW YORK, NY, 10010
- Phone: (908) 662-4252
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Osamah Choudhry | Director | New York, NY |
| Christopher Morley | Director | New York, NY |
| Osamah Choudhry | Executive Officer | New York, NY |
| Christopher Morley | Executive Officer | New York, NY |
More